farrell, I have been reading between the lines regarding the PR, What about a scenario like, "expanded IND", once the human trial is complete and they have done further testing to include the Virus and common cold therapy:
"clinical stage biopharmaceutical company, today announces additional independent preliminary laboratory research suggests Brilacidin, the Company’s flagship defensin mimetic, has the potential to treat other endemic human coronaviruses (H-CoVs), such as those causing common colds, and not just SARS-CoV-2, the novel coronavirus responsible for the ongoing global COVID-19 pandemic."

Than we have the IBD for top to bottom, waiting in the, well...............(wings